Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Feb 28, 2022; 28(8): 840-852
Published online Feb 28, 2022. doi: 10.3748/wjg.v28.i8.840
Table 2 Clinical outcomes and adverse events of early gastric cancer resection according to treatment modality
Variables
ESD (n =119)
Surgery (n = 119)
P value
Median hospital stay, d (IQR)4.0 (4.0-5.0)9.0 (8.0-9.0)< 0.001
ICU admission, n (%)1 (0.8)0 (0.0)-
30-d readmission, n (%)3 (2.5)12 (1.7)2-
Operation-related death, n (%)1 (0.8)0 (0.0)-
Complication, n (%)14 (11.8)7 (5.9)0.110
Bleeding (early/late)8/00/0
Perforation (early/late)5/0N/A
Pneumonia (early/late)1/00/0
Anastomosis site leakage (early/late)N/A1/0
Adhesion or bowel obstruction (early/late)0/01/2
Hernia (early/late)N/A1/2